AXA Investment Managers’s Thermo Fisher Scientific TMO Stock Holding History

AXA Investment Managers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$196M	Buy	+403,144	New	+$188M	0.53%	36

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AXA Investment Managers's TMO Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Thermo Fisher Scientific (TMO) in Q3 2025: 403,144 shares worth $196M. The stake represents 0.53% of the portfolio and ranks #36 among its holdings.

2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

AXA Investment Managers held 403,144 shares of Thermo Fisher Scientific worth $196M as of Q3 2025.
Thermo Fisher Scientific was a new AXA Investment Managers position in Q3 2025.
Thermo Fisher Scientific made up 0.53% of AXA Investment Managers's portfolio in Q3 2025, its #36 holding.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.